Navigation Links
Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
Date:4/10/2013

receptors, and the EAE data further underscore the potential for the compounds that we have identified with our CRA. There are no approved remyelinating therapeutics – all approved agents for the treatment of MS are anti-inflammatories. The GPR17 antagonists that we are developing could lead to the first drug able to promote remyelination and restore neural function in patients with MS."

Ongoing GPCR Program

Omeros is screening orphan and difficult-to-drug Class A and Class B GPCRs against its small-molecule chemical libraries using its proprietary, high-throughput cellular redistribution assay (CRA). The CRA detects receptor antagonists, agonists, inverse agonists and allosteric modulators for a given GPCR without requiring the receptor's ligand or any knowledge of the receptor's signaling pathway(s). Omeros has announced that it has identified and confirmed sets of compounds that interact selectively with 46 Class A orphan receptors linked to metastatic melanoma (GPR19), esophageal squamous cell carcinoma and obesity-related type-2 diabetes (GPR39), hepatocellular carcinoma (GPR80), several types of cancer (GPR65/TDAG8), squamous cell carcinoma (GPR87), ovarian cancer (GPR150), pancreatic cancer (GPR182), acute lymphoblastic leukemia (P2Y8/P2RY8), ovarian and prostate cancer (OGR1), arterial stiffness (GPR25), sleep disorders (OPN4), cognitive disorders (GPR12), torpor or "suspended animation" and bipolar disorder (GPR50), anxiety disorders (GPR31), schizophrenia (GPR52, GPR153), autism (GPR63), bipolar disorder and schizophrenia (GPR78), memory and inflammatory conditions (GPR83), psychotic and metabolic disorders (GPR27, GPR85, GPR173), cognition (GPR151), cognitive impairments (MAS1), inflammatory responses (GPR32), obesity and diabetes (GPR21), appetite control (GPR82, GPR101), immunological disorders (CCRL2), rheumatoid arthritis and HIV-mediated enteropathy (GPR15), respiratory and immune disorders (GPR141), humoral immunity (GPR183), mu
'/>"/>

SOURCE Omeros Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Omeros Announces Positive OMS721 Data in Model of Thrombotic Microangiopathy
2. Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
3. Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
4. Omeros Announces Successful Completion of PDE10 Phase 1 Multiple Ascending Dose Trial
5. Omeros Elucidates Mechanism of its PDE7 Inhibitors in Addiction
6. Omeros to Present at the Cowen and Company 33rd Annual Health Care Conference
7. Omeros Announces Toxicology Study Data from MASP-2 Inhibitor
8. Omeros Announces Positive OMS302 Safety Data in Phase 3 Clinical Trial
9. Omeros Announces Encouraging Data from Phase 1 Clinical Trial for PDE10 Program
10. Omeros to Present at the 24th Annual Piper Jaffray Health Care Conference
11. Omeros is Not Aware of Any Justification for Share Price Movement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... --  TRU-D SmartUVC LLC, producers of the first ... that the General Services Administration has awarded the company ... This newly formed agreement will allow TRU-D SmartUVC ... including Department of Veteran Affairs and Department of Defense ... solutions for the Ebola effort in West ...
(Date:12/22/2014)... Cyberonics, Inc. (NASDAQ: CYBX ), a ... of epilepsy, today announced it will participate in the 33 ... 14, 2015, in San Francisco . ... Officer, will speak at 11:00 AM Pacific Time.  A live ... on the Investor Relations link on the Cyberonics home page ...
(Date:12/22/2014)...  Mark Farrah Associates (MFA), www.markfarrah.com , ... the 2015 marketplace exchange projections and insights about ... According to a recent ASPE (Office of the ... Health and Human Services) report, an estimated 6.7 ... through the Marketplace as of October 2014 and ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2Insights into the Marketplace and Individual Market Growth 2
... 29, 2011 Reportlinker.com announces that a new market ... Orthopedics Markets http://www.reportlinker.com/p0368861/Orthopedics-Markets.html ... deals with the diagnosis and treatment of disorders and ... and ligaments associated with it. The orthopedics market has ...
... Pa. and MELBOURNE, Australia, March 28, 2011 ... ChemGenex Pharmaceuticals Limited (ASX: CXS) today jointly announced ... Ltd, intends to make a takeover bid for ... developing its lead product candidate, OMAPRO™, for the ...
Cached Medicine Technology:Reportlinker Adds Orthopedics Markets 2Reportlinker Adds Orthopedics Markets 3Reportlinker Adds Orthopedics Markets 4Reportlinker Adds Orthopedics Markets 5Reportlinker Adds Orthopedics Markets 6Reportlinker Adds Orthopedics Markets 7Reportlinker Adds Orthopedics Markets 8Reportlinker Adds Orthopedics Markets 9Reportlinker Adds Orthopedics Markets 10Reportlinker Adds Orthopedics Markets 11Reportlinker Adds Orthopedics Markets 12Reportlinker Adds Orthopedics Markets 13Reportlinker Adds Orthopedics Markets 14Reportlinker Adds Orthopedics Markets 15Reportlinker Adds Orthopedics Markets 16Reportlinker Adds Orthopedics Markets 17Reportlinker Adds Orthopedics Markets 18Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 2Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 3Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 4Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 5Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 6Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 7Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 8Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 9Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 10Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 11Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 12Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 13Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 14Cephalon Launches Recommended Takeover Bid For Australian Biopharmaceutical Company, ChemGenex Pharmaceuticals Limited 15
(Date:12/22/2014)... As early as thirty, gravity begins ... the form of “jowls." The dreaded droopiness usually appears ... marionette line or smile lines. Aging can be fought ... as the deep facial tissues descend, jowls inevitably appear. ... that can be used under the skin to fill ...
(Date:12/22/2014)... (PRWEB) December 22, 2014 The founders ... BLS and ACLS online certification provider, are proud to ... . The updated site now features a more user-friendly ... ever to use. , As a company spokesperson ... is now consolidated into a single page during the ...
(Date:12/22/2014)... Dec. 19, 2014 (HealthDay News) -- U.S. and state ... caramel apples that has killed at least four people ... should not eat any commercially produced, prepackaged caramel apples ... Disease Control and Prevention said in a news release. ... people had been infected with the outbreak strains of ...
(Date:12/22/2014)... 2014 Super Saturday, the last Saturday ... as the busiest day in the 2014 holiday shopping ... Station had a steady pre-Christmas stream of customers, ready ... Saturday. , “I definitely intend to take advantage…of the ... resident who was enjoying The Grass Station’s holiday sale ...
(Date:12/22/2014)... In recognition of Veteran’s Day, Discount ... Reward, a local organization that provides services to veterans ... Located on a couple hundred acres in the hills ... world class fishing, hunting, hiking, horseback riding, 4-wheeling, skeet ... years ago to support U.S. Service men and women, ...
Breaking Medicine News(10 mins):Health News:Sam Rizk, MD, FACS, Introduces Rapid Recovery Facelift 2Health News:ACLS Online Certification Website ACLS-PALS-BLS.com Now Features a New and User-Friendly Layout 2Health News:CDC Warns of Listeria Danger From Caramel Apples 2Health News:Customers at Colorado’s Grass Station Say They’re Enjoying the Experience of Legally Purchasing Marijuana this Year to Give as Christmas Presents to Friends and Family 2Health News:Discount Labels Donates Portion of November Sales to Hero Reward Program 2
... ROCHESTER, Minn. -- Hospitalization for underage drinking is common in ... -- the estimated total cost for these hospitalizations is about ... Researchers also found geographic and demographic differences in the ... today in the Journal of Adolescent Health . ...
... SASKATOON, SASKATCHEWAN - A research project exploring the potential ... instead of a nuclear reactor is about to move to ... Canadian Light Source (CLS) and partners including the National Research ... Toronto, is set to scale up their work to production ...
... study conducted by researchers at Moffitt Cancer Center in Tampa, ... that female cancer survivors receiving screening mammography have "worse health ... had cancer. The study was published in a recent ... Researchers surveyed 19,948 women age 35 and older presenting ...
... -- Babies can understand many words sooner than they can ... the University of Pennsylvania say 6- to 9-month old babies ... body parts through their daily exposure to language. They said ... possible until a child is closer to 1 year. ...
... we all wish for good caregiving during the final ... Institutet and Ume University shows that non-pharmacological caregiving at ... not as basic as one might believe but is ... and existential dimensions into a functional whole. The researchers ...
... drugs known as photodynamic therapy can destroy cancer ... The reason that internal tumours are not treated with the ... that the precise amount of light is administered. However, software ... Sweden looks like being able to solve the problem. ...
Cached Medicine News:Health News:Mayo Clinic: Hospitalization of US underage drinkers common, costs $755 million a year 2Health News:Canadian Isotope Project enters final stretch 2Health News:Female cancer survivors have 'worse health behaviors' than women with no cancer history 2Health News:Babies May Be Smarter Than You Think 2Health News:Complexities in caregiving at the end of life 2Health News:New method makes it easier to treat prostate and pancreatic cancer 2
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
... Centuries of German Craftsmanship ... surgical instrumentation in the ... them available to you! ... coveted Meisterbrief certificate, which ...
Protects the eye from symptoms caused by "dry eye, medical conditions, drug reactions and environmental factors. Forms a moisture chamber over the eye area during rest....
... Medtronic Ophthalmics offers the most ... specialty Eraser Instruments for Cataract incision, ... and discrete coagulation is achieved with ... cellular necrosis. Straight eraser styles are ...
Medicine Products: